Amogechukwu N Okonkwo, MD - Medicare Family Practice in Syracuse, NY

Amogechukwu N Okonkwo, MD is a medicare enrolled "Family Medicine" physician in Syracuse, New York. She graduated from medical school in 1998 and has 26 years of diverse experience with area of expertise as Family Practice. She is a member of the group practice Faxton-st Lukes Healthcare, New York General Medical Services Pc and her current practice location is 819 S Salina St, Syracuse, New York. You can reach out to her office (for appointments etc.) via phone at (315) 476-7921.

Amogechukwu N Okonkwo is licensed to practice in New York (license number 238876) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1053378612.

Contact Information

Amogechukwu N Okonkwo, MD
819 S Salina St,
Syracuse, NY 13202-3536
(315) 476-7921
(315) 475-1448



Physician's Profile

Full NameAmogechukwu N Okonkwo
GenderFemale
SpecialityFamily Practice
Experience26 Years
Location819 S Salina St, Syracuse, New York
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Amogechukwu N Okonkwo graduated from medical school in 1998
  NPI Data:
  • NPI Number: 1053378612
  • Provider Enumeration Date: 04/27/2006
  • Last Update Date: 01/30/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 3971514233
  • Enrollment ID: I20060526000134

Medical Identifiers

Medical identifiers for Amogechukwu N Okonkwo such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053378612NPI-NPPES
02745173MedicaidNY

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 238876 (New York)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Faxton-st Luke's HealthcareUtica, NYHospital
Loretto Health And Rehabilitation CenterSyracuse, NYNursing home

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Faxton-st Lukes Healthcare2769380252291
New York General Medical Services Pc781025549427

News Archive

Discovery may lead to immunosuppressant drugs that have fewer adverse side effects

Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases.

A 'cocktail' to kill cancerous tumors

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

Longer looks: Health policy picks that will fascinate, captivate

Thirty-four states have some type of HIV-criminalization law. Depending on the state, it may be illegal to expose someone else to HIV, transmit the virus or conceal your own HIV-positive status from potential sexual partners. This criminalization extends even to cases in which condoms were used or when the virus was not transmitted, as well as to acts, such as spitting or biting, that pose minuscule to no risk.

Breast cancer treatment more effective when determined by tumor cell count

Research published today shows that circulating tumor cell count may provide an effective indicator of appropriate treatment choice for metastatic breast cancer.

CTI responds to EMA's Day 120 letter for pixantrone MAA

Cell Therapeutics, Inc. today announced that it has submitted its response to the Day 120 List of Outstanding Issues to the European Medicines Agency's Committee for Medicinal Products for Human Use in regards to CTI's Marketing Authorization Application for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Amogechukwu N Okonkwo allows following entities to bill medicare on her behalf.
Entity NameFaxton-st Lukes Healthcare
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1770690737
PECOS PAC ID: 2769380252
Enrollment ID: O20031222000433

News Archive

Discovery may lead to immunosuppressant drugs that have fewer adverse side effects

Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases.

A 'cocktail' to kill cancerous tumors

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

Longer looks: Health policy picks that will fascinate, captivate

Thirty-four states have some type of HIV-criminalization law. Depending on the state, it may be illegal to expose someone else to HIV, transmit the virus or conceal your own HIV-positive status from potential sexual partners. This criminalization extends even to cases in which condoms were used or when the virus was not transmitted, as well as to acts, such as spitting or biting, that pose minuscule to no risk.

Breast cancer treatment more effective when determined by tumor cell count

Research published today shows that circulating tumor cell count may provide an effective indicator of appropriate treatment choice for metastatic breast cancer.

CTI responds to EMA's Day 120 letter for pixantrone MAA

Cell Therapeutics, Inc. today announced that it has submitted its response to the Day 120 List of Outstanding Issues to the European Medicines Agency's Committee for Medicinal Products for Human Use in regards to CTI's Marketing Authorization Application for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma.

Read more Medical News

› Verified 7 days ago

Entity NameTed J Triana Do Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1992243687
PECOS PAC ID: 1254424211
Enrollment ID: O20070906000667

News Archive

Discovery may lead to immunosuppressant drugs that have fewer adverse side effects

Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases.

A 'cocktail' to kill cancerous tumors

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

Longer looks: Health policy picks that will fascinate, captivate

Thirty-four states have some type of HIV-criminalization law. Depending on the state, it may be illegal to expose someone else to HIV, transmit the virus or conceal your own HIV-positive status from potential sexual partners. This criminalization extends even to cases in which condoms were used or when the virus was not transmitted, as well as to acts, such as spitting or biting, that pose minuscule to no risk.

Breast cancer treatment more effective when determined by tumor cell count

Research published today shows that circulating tumor cell count may provide an effective indicator of appropriate treatment choice for metastatic breast cancer.

CTI responds to EMA's Day 120 letter for pixantrone MAA

Cell Therapeutics, Inc. today announced that it has submitted its response to the Day 120 List of Outstanding Issues to the European Medicines Agency's Committee for Medicinal Products for Human Use in regards to CTI's Marketing Authorization Application for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma.

Read more Medical News

› Verified 7 days ago

Entity NameSt Josephs Medical Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942501747
PECOS PAC ID: 4688855844
Enrollment ID: O20110221000744

News Archive

Discovery may lead to immunosuppressant drugs that have fewer adverse side effects

Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases.

A 'cocktail' to kill cancerous tumors

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

Longer looks: Health policy picks that will fascinate, captivate

Thirty-four states have some type of HIV-criminalization law. Depending on the state, it may be illegal to expose someone else to HIV, transmit the virus or conceal your own HIV-positive status from potential sexual partners. This criminalization extends even to cases in which condoms were used or when the virus was not transmitted, as well as to acts, such as spitting or biting, that pose minuscule to no risk.

Breast cancer treatment more effective when determined by tumor cell count

Research published today shows that circulating tumor cell count may provide an effective indicator of appropriate treatment choice for metastatic breast cancer.

CTI responds to EMA's Day 120 letter for pixantrone MAA

Cell Therapeutics, Inc. today announced that it has submitted its response to the Day 120 List of Outstanding Issues to the European Medicines Agency's Committee for Medicinal Products for Human Use in regards to CTI's Marketing Authorization Application for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma.

Read more Medical News

› Verified 7 days ago

Entity NameNew York General Medical Services Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1700315538
PECOS PAC ID: 7810255494
Enrollment ID: O20180103003151

News Archive

Discovery may lead to immunosuppressant drugs that have fewer adverse side effects

Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases.

A 'cocktail' to kill cancerous tumors

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

Longer looks: Health policy picks that will fascinate, captivate

Thirty-four states have some type of HIV-criminalization law. Depending on the state, it may be illegal to expose someone else to HIV, transmit the virus or conceal your own HIV-positive status from potential sexual partners. This criminalization extends even to cases in which condoms were used or when the virus was not transmitted, as well as to acts, such as spitting or biting, that pose minuscule to no risk.

Breast cancer treatment more effective when determined by tumor cell count

Research published today shows that circulating tumor cell count may provide an effective indicator of appropriate treatment choice for metastatic breast cancer.

CTI responds to EMA's Day 120 letter for pixantrone MAA

Cell Therapeutics, Inc. today announced that it has submitted its response to the Day 120 List of Outstanding Issues to the European Medicines Agency's Committee for Medicinal Products for Human Use in regards to CTI's Marketing Authorization Application for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma.

Read more Medical News

› Verified 7 days ago

Entity NameNv Pacs 2 Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1427534809
PECOS PAC ID: 0941550578
Enrollment ID: O20210831002021

News Archive

Discovery may lead to immunosuppressant drugs that have fewer adverse side effects

Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases.

A 'cocktail' to kill cancerous tumors

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

Longer looks: Health policy picks that will fascinate, captivate

Thirty-four states have some type of HIV-criminalization law. Depending on the state, it may be illegal to expose someone else to HIV, transmit the virus or conceal your own HIV-positive status from potential sexual partners. This criminalization extends even to cases in which condoms were used or when the virus was not transmitted, as well as to acts, such as spitting or biting, that pose minuscule to no risk.

Breast cancer treatment more effective when determined by tumor cell count

Research published today shows that circulating tumor cell count may provide an effective indicator of appropriate treatment choice for metastatic breast cancer.

CTI responds to EMA's Day 120 letter for pixantrone MAA

Cell Therapeutics, Inc. today announced that it has submitted its response to the Day 120 List of Outstanding Issues to the European Medicines Agency's Committee for Medicinal Products for Human Use in regards to CTI's Marketing Authorization Application for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Amogechukwu N Okonkwo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Amogechukwu N Okonkwo, MD
819 S Salina St,
Syracuse, NY 13202-3536

Ph: () -
Amogechukwu N Okonkwo, MD
819 S Salina St,
Syracuse, NY 13202-3536

Ph: (315) 476-7921

News Archive

Discovery may lead to immunosuppressant drugs that have fewer adverse side effects

Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases.

A 'cocktail' to kill cancerous tumors

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

Longer looks: Health policy picks that will fascinate, captivate

Thirty-four states have some type of HIV-criminalization law. Depending on the state, it may be illegal to expose someone else to HIV, transmit the virus or conceal your own HIV-positive status from potential sexual partners. This criminalization extends even to cases in which condoms were used or when the virus was not transmitted, as well as to acts, such as spitting or biting, that pose minuscule to no risk.

Breast cancer treatment more effective when determined by tumor cell count

Research published today shows that circulating tumor cell count may provide an effective indicator of appropriate treatment choice for metastatic breast cancer.

CTI responds to EMA's Day 120 letter for pixantrone MAA

Cell Therapeutics, Inc. today announced that it has submitted its response to the Day 120 List of Outstanding Issues to the European Medicines Agency's Committee for Medicinal Products for Human Use in regards to CTI's Marketing Authorization Application for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma.

Read more News

› Verified 7 days ago


Family Medicine Doctors in Syracuse, NY

Amy Elizabeth Roy, NP
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1000 E Genesee St, Suite 300, Syracuse, NY 13210
Phone: 315-471-1044    Fax: 315-474-4312
Andrew Paul Aiken, FNP
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 800 Irving Ave, Va Medical Center Outpatient Cardiology, Syracuse, NY 13210
Phone: 315-425-4400    
Pamela Sue Horst, MD
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 301 Prospect Ave, Palliative Care, Syracuse, NY 13203
Phone: 315-448-5175    Fax: 315-448-3557
Kevin E Gaskin, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 750 E Adams St, Syracuse, NY 13210
Phone: 315-464-4363    Fax: 315-464-8690
Brigitte Mcgrath,
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 847 James St, Syracuse, NY 13203
Phone: 315-471-1184    
Matthew Micco, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 301 Prospect Ave, Syracuse, NY 13203
Phone: 315-448-5536    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.